Skip to main content
Explore URMC



Lisa A. Beck, M.D.

Dermatology, Medicine

Clinical Interests

Atopic Dermatitis, Eczema; General Dermatology; Urticaria, Hives (Adult & Pediatric)

Contact Information

Phone Numbers

Appointment: (585) 275-7546

Office: (585) 275-1039

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments


Dr. Beck brings more than 20 years' experience to the treatment of atopic dermatitis and eczema. She is currently involved in an NIH-funded study to determine why certain patients are susceptible to the herpes simplex and Staphylococcus aureus viruses. Dr. Beck received her undergraduate degree from Mount Holyoke College and her medical degree from the State University of New York at Stony Brook.


Dr. Beck's research interests are in three interrelated areas. First, we are interested in characterizing the epithelial tight junction defects at the molecular level in atopic dermatitis, the most common inflammatory skin disease in man. Numerous projects radiate from that central theme and include – 1) how do these defects differ in other inflammatory skin diseases such as chronic urticaria, psoriasis, CTCL, 2) what effects do various pharmacologic agents have on TJ function and structure, 3) can protease containing allergens or microbes affect TJ function and if so how. A second area of focus is evaluating the magnitude and character of the microbial responsiveness of keratinocytes (cutaneous epithelial cells) from atopic dermatitis subjects compared to nonatopic healthy controls. When differences are noted we are trying to determine the basis for these differences and believe this line of inquiry may explain AD subjects' susceptibility to colonization and infection with numerous bacteria, viruses and even yeast. Our third area has been to understand why there is such a paucity of tissue neutrophils in lesions from subjects with atopic dermatitis. These studies are not as advanced but suggest that there are phenotypic differences in AD neutrophils' responsiveness to the potent chemoattractant, IL-8 (CXCL8) compared to nonatopic controls.



  • Dermatology - American Board of Dermatology


BA | Mount Holyoke College

MD | Stony Brook Univ Health Sciences Center School of Medicine

Post-doctoral Training & Residency

07/01/1987 - 07/31/1990
Residency in Dermatology at Duke University Medical Center

07/01/1986 - 07/31/1987
Residency in Internal Medicine at University of Rochester Medical Center

06/27/1985 - 07/31/1986
Internship in Internal Medicine at University of Rochester Medical Center

VIEW ALL expand_more


Dermatology Faculty Teaching Award
Sponsor: University of Rochester Medical Center

Mentor for NEASE Skin Research Grant Recipient
Sponsor: NEASE

Mentor for AAAAI Summer Research Grant Recipient
Sponsor: AAAAI

Mentor for Astellas Skin Research Grant Recipient
Sponsor: Astellas

Mentor for Fujisawa AAAAI Research Grant Recipient
Sponsor: Fujisawa

Mentor for Howard Hughes Summer Fellowship Recipient
Sponsor: Howard Hughes

Physician-Scientist Award
Sponsor: National Institute of Health

Research Award
Sponsor: Dermatology Foundation

Teaching Appreciation Award
Sponsor: Johns Hopkins University
Location: Dermatology Department

Internal Medicine Teaching Award
Sponsor: Francis Scott Key Medical Center

VIEW ALL expand_more


Title: Designed Peptides for Tight Junction Barrier Modulation
U.S. Serial #: 14/912,098
Filed: Aug 18, 2014
Invented By: ElizabethAnderson, LisaBeck, AnnaDe Benedetto, BenjaminMiller

Title: System and Method for Studying Epidermis Samples Ex Vivo
U.S. Serial #: 13/743,879
Filed: Jan 17, 2013
Invented By: LisaBeck, AnnaDe Benedetto


Journal Articles

Li S, Villarreal M, Stewart S, Choi J, Indra G, Babineau DC, Philpot C, David G, Yoshida T, Boguniewicz M, Hanifin J, Beck LA, Leung D, Simpson E, Indra AK. "Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis." The British journal of dermatology.. 2017 Oct 0; 177(4):e125-e127. Epub 2017 Sep 05.

Kwon CW, Land AS, Smoller BR, Scott G, Beck LA, Mercurio MG. "Bullous pemphigoid associated with nivolumab, a programmed cell death 1 protein inhibitor." Journal of the European Academy of Dermatology and Venereology : JEADV.. 2017 Aug 0; 31(8):e349-e350. Epub 2017 Mar 03.

Leung DY, Jepson B, Beck LA, Hanifin JM, Schneider LC, Paller AS, Monti K, David G, Canniff J, Lorenzo MG, Weinberg A. "A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis." The Journal of allergy and clinical immunology.. 2017 May 0; 139(5):1575-1582.e8. Epub 2017 Feb 13.

Books & Chapters

Chapter Title: Update on the Managment of Atopic Dermatitis
Book Title: Allergy Frontiers: Epigenetics to Future Perspectives
Author List: Ibrahim SF, DeBenedetto A, Beck LA
Edited By: Pawankar R, Holgate S, Rosenwasser L
Published By: Springer2008 in Tokyo, Japan

Chapter Title: Regulation of the Production and Activation of Eosinophils and Neutrophils
Book Title: Dermatology in General Medicine
Author List: Beck LA, Loveless J, Holland S
Edited By: Freedberg I, Katz S, Wolff K, Eisen A, Austen KF and Goldsmith L
Published By: McGraw-Hill Co.2007 in New York

Chapter Title: Dermatitis
Book Title: Current Therapy in Allergy, Immunology and Rheumatology
Author List: Beck LA
Edited By: Lichtenstein LM, Busse WW and Geha RS
Published By: Mosby Yearbook Inc.2004 in St. Louis